4-Chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine

Catalog No. :
ACCETX637
CAS No. :
529508-56-3
Molecular Formula :
C7H6ClN3
Molecular Weight :
167.60

IUPAC Name:4-chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine

4-Chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$101.00Login to see priceIn stockInquiry
250mg97%$136.00Login to see priceIn stockInquiry
1g97%$335.00Login to see priceIn stockInquiry
5g97%$1025.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine
IUPAC Name4-chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine
MDL No.MFCD12924549
Molecular FormulaC7H6ClN3
Molecular Weight167.60
SMILESCC1=C2C(Cl)=NC=NN2C=C1
InChI KeyCBQDXECHDATNTG-UHFFFAOYSA-N
SynonymCS-M1181 | AKOS015920256 | AM20100297 | MFCD12924549 | 4-chloro-5-methyl-Pyrrolo[2,1-f][1,2,4]triazine | 4-Chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine | DTXSID30619220 | PB16527 | J-515067 | FT-0685179 | AS-38915 | CBQDXECHDATNTG-UHFFFAOYSA-N | SCHEMBL12
CAS No.529508-56-3
PubChem CID21874227

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCETX637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIGH240 route compound structure diagram
    ACKIGH240529508-54-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCETX637 route product structure diagram
    ACCETX637529508-56-3 In Stock
Inquiry

2. ACCETX637 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTCMS216 route compound structure diagram
    ACTCMS2161823367-63-0 In Stock
  2. Then
  3. ACCETX637 route product structure diagram
    ACCETX637529508-56-3 In Stock
Inquiry

Comments (0)